Abstract
Korean researchers, in collaboration with American scientists, have generated the world's first patient-specific human embryonic stem cells (hESCs), with promising implications for future therapeutic strategies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hwang, W.S. et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science; published online 19 May 2005.
Hwang, W.S. et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 303, 1669–1674 (2004).
Rights and permissions
About this article
Cite this article
Eisenstein, M. Stem cell match-making. Nat Methods 2, 482–483 (2005). https://doi.org/10.1038/nmeth0705-482b
Issue Date:
DOI: https://doi.org/10.1038/nmeth0705-482b